Statistics for Nutex Health, (id:5341 NUTX)
Valuation metrics
Market cap
159.74M
Enterprise value
435.52M
Trailing P/E (ttm)
1.42
Forward P/E
19.59
PEG ratio
19.59
Price/Sales (ttm)
3.00
Price/Book (mrq)
2.54
Enterprise Value/Revenue
1.49
Enterprise Value/EBITDA
12.03
Overview
Shares outstanding
5.44M
Float
3.27M
Shares short
44.59K
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
42.70K
Average volume (90 days)
Price summary
52-Week low
4.16
52-Week high
41.44
52-Week change
-2.11%
Beta
1.79
50-Day moving average
29.20
200-Day moving average
16.12
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 1, 2019
Ex-dividend date
Last split factor
2:1
Last split date
July 3, 2024
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-14.09%
Operating margin
12.80%
Operational effectiveness
Return on assets
3.76%
Return on equity
-35.10%
Income statement
Revenue (ttm)
60.20
Revenue per share (ttm)
60.20
Quarterly revenue growth (yoy)
Gross profit (ttm)
34.77M
EBITDA
46.34M
Net income to common (ttm)
-41,134,332.00
Diluted EPS (ttm)
-9.18
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
46.91M
Total cash per share (mrq)
8.63
Total debt (mrq)
303.24M
Total Debt/Equity (mrq)
380.10
Current ratio (mrq)
177.30%
Book value per share (mrq)
11.59
Cash flow
Cash flow statement
21.32M
Levered free cash flow (LFCF)
23.91M